Abstract:75 Objectives Parkinson disease (PD), multiple system atrophy (MSA) and progressive supranuclear palsy (PSP) are all known to affect dopaminergic neurons and often present with similar clinical features. Dopamine transporter (DAT) imaging can demonstrate presynaptic dopaminergic neuronal loss in PD, MSA and PSP. However, differentiating atypical parkinsonism from PD is often difficult. In this study, we investigated differences in striatal subregional DAT loss in PD, MSA and PSP, as well as the diagnostic value of 11C-CFT PET imaging in the differential diagnosis of parkinsonism. Methods Brain 11C-CFT PET imaging was performed in 219 patients with parkinsonian disorders. The PET images were spatially normalized and a standardized set of regions of interest (ROIs) were defined bilaterally for the caudate, anterior putamen (AP), posterior putamen(PP), ventral putamen (VP), dorsal putamen (DP) and occipital cortex with ScAnVP software. The nondisplaceable binding potential (BPND; defined as the ratio of (striatum-occipital)/occipital radioactivity counts) of each striatal subregion and intersubregional ratio (ISR; defined as the ratio of the BPND of one subregion to that of another subregion) were calculated. After the imaging, these patients were assessed by blinded movement disorders specialists for a mean of 2.3 years before a final clinical diagnosis was made. The accuracy of DAT imaging-based classification was assessed by comparison with the final clinical diagnosis. Results 133 patients had a final clinical diagnosis of PD, 55 MSA, and 31 PSP with severity matched. The BPND of caudate in the PSP group was significantly lower than those in the PD and MSA groups. The ISR of each subregional putamen/caudate in the PSP group was significantly higher than those in the PD and MSA groups. At the cutoff value of 1.16, the AP/C ISR had 87%sensitivity and 93% specificity for differentiating PSP from PD. The classifications were also accurate for PP/C (0.63; 80% sensitivity, 88% specificity), VP/C (1.13; 87% sensitivity, 92% specificity) and DP/C (0.87; 87% sensitivity, 90% specificity) ISRs. At the cutoff value of 1.23, the AP/C ISR had 81% sensitivity and 87% specificity for differentiating PSP from MSA. The classifications were also accurate for PP/C (0.78; 68% sensitivity, 84% specificity), VP/C (1.15; 84% sensitivity, 86% specificity) and DP/C (0.98; 81% sensitivity, 82% specificity) ISRs. The BPND of DP and the ISRs of DP/non-DP subregions in the MSA group were significantly higher than those in the PD group. At the cutoff value of 0.81, the DP/AP ISR had 76% sensitivity and 82% specificity for differentiating MSA from PD. The classifications were also accurate for DP/C (0.76; 71% sensitivity, 75% specificity) and DP/VP (0.87; 76% sensitivity, 76% specificity) ISRs. Conclusions PD, MSA and PSP have different preferential subregional decreases in striatal DAT binding when examined by 11C-CFT PET imaging. The ISRs could provide valuable information to distinguish parkinsonian disorders, even in earlier stages of disease.

Patterns of Dopamine Transporter Imaging in Subtypes of Multiple System Atrophy

Dopamine Transporter PET Imaging in Patients with Parkinson Variant of Multiple System Atrophy and Parkinson''s Disease

In Vivo Cerebral Metabolic and Dopaminergic Characteristics in Multiple System Atrophy with Orthostatic Hypotension.

Dopamine Transporter Imaging in Progressive Supranuclear Palsy: Severe but Nonspecific to Subtypes

Subregional Patterns of Preferential Striatal DAT Loss Differ in PD, MSA and PSP

123I-FP-CIT SPECT Accurately Distinguishes Parkinsonian From Cerebellar Variant of Multiple System Atrophy

Differentiation of Cerebellum-Type and Parkinson-Type of Multiple System Atrophy by Using Multimodal MRI Parameters

Surface-Based Neuroimaging Pattern of Multiple System Atrophy

Neuroimaging Features of Multiple System Atrophy

Distinct Patterns of Electrophysiologic-Neuroimaging Correlations Between Parkinson's Disease and Multiple System Atrophy

18F-Florzolotau Tau Positron Emission Tomography Imaging in Patients with Multiple System Atrophy-Parkinsonian Subtype

Advanced Cognitive Patterns in Multiple System Atrophy Compared to Parkinson’s Disease: An Individual Diffusion Tensor Imaging Study

Clinical features, MRI, and 18F‐FDG‐PET in differential diagnosis of Parkinson disease from multiple system atrophy

Reproducible metabolic topographies associated with multiple system atrophy: Network and regional analyses in Chinese and American patient cohorts

The Study of 11C-Cft Pet Dopamine Transporter Imaging in Evaluating the Severity of Pd

Dopamine Transporter PET Imaging in Patients with Progressive Supranuclear Palsy and Parkinson's Disease

Cerebral Metabolism Related to Cognitive Impairments in Multiple System Atrophy

Characterization and diagnostic potential of diffusion tractography in multiple system atrophy

Comparison of spontaneous brain activity in distinguishing parkinsonian variant of multiple system atrophy from Parkinson's disease at an early stage

Diffusion imaging technology in the differential diagnosis of multiple system atrophy

Automated Analysis of Diffusion‐Weighted Magnetic Resonance Imaging for the Differential Diagnosis of Multiple System Atrophy from Parkinson's Disease